Find a research project
Browse our clinical research projects. Find a project you'd like to join. Filter the list by condition / recruiting status.

Horizon
A study to investigate multiple sclerosis relapse prevention with mRNA-1195 compared with placebo in participants aged 18 to 55 years.

NeuroCARE
Our platform for people in Scotland with a neurological condition, and their carers, to sign up to help research and find out about opportunities to take part in studies and trials.

DASH - Digital App for Speech & Health Monitoring
This project investigates the use of speech recordings and user-friendly technologies to better understand, diagnose and monitor neurodegenerative conditions and dementia.

Octopus Clinical Trial
A multi-arm, multi-stage clinical drug trial for people with progressive MS.

MND-SMART
An innovative clinical drugs trial testing potential new treatments that may slow, stop or reverse the progression of MND.

ALS-Biomarkers
ALS-Biomarkers aims to collect a range of biomarkers that could be used to better understand motor neuron disease (MND) and improve clinical care.

ON-FIRE
ON-FIRE is collecting a large number of blood samples and clinical information from people with frontotemporal dementia (FTD), aiming to identify patterns of inflammation in the blood among different individuals.

CANnabidiol for Parkinson’s Disease Psychosis (CAN-PDP)
A clinical drug trial testing whether Cannabidiol reduces symptoms of psychosis in people with Parkinson's.

COBALT (COmBining memantine And cholinesterase inhibitors in Lewy body dementia Treatment trial)
A randomised controlled clinical drug trial for people living with Parkinson's or Lewy Body Dementias.

TOP-HAT (Trial of Ondansetron as a Parkinson’s Hallucinations Treatment)
This trial is testing whether ondansetron will be an effective and safe treatment for visual hallucinations in people with Parkinson’s or those with Lewy Body Dementia.

EXPERTS-ALS: EXPErimental medicine Route To Success in Amyotrophic Lateral Sclerosis
A multi-centre clinical trial platform that uses blood neurofilament light chain levels as a marker of disability progression.

ASPIRING
Antiplatelet Secondary Prevention International Randomised study after INtracerebral haemorrhaGe